The Proportion of Patients Diagnosed With Dry Eye by the Asia Dry Eye Society (ADES) Criteria in Taiwan (DECS-TW)
NCT05096546 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 540
Last updated 2022-05-27
Summary
The study aims to determine the proportion of patients diagnosed with dry eye by the Asia Dry Eye Society (ADES) criteria, among patients diagnosed with dry eye disease under current hospital-based practice in Taiwan.
Conditions
- Dry Eye Syndromes
Interventions
- OTHER
-
No intervention
No intervention will be applied for the observational study.
Sponsors & Collaborators
-
Santen Pharmaceutical (Taiwan) Co., LTD
collaborator INDUSTRY -
Kaohsiung Medical University
collaborator OTHER -
Taipei Veterans General Hospital, Taiwan
collaborator OTHER_GOV -
Far Eastern Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-21
- Primary Completion
- 2022-02-28
- Completion
- 2022-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye Symptoms
NCT05825352 ·Status: COMPLETED ·Phase: NA
-
Clinical Feature and Treatment of Microsporidial Keratoconjunctivitis
NCT03555409 ·Status: UNKNOWN
-
Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye
NCT05193331 ·Status: UNKNOWN ·Phase: NA
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
NCT07078955 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease
NCT03364322 ·Status: COMPLETED
-
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
NCT00848198 ·Status: COMPLETED
-
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
NCT03557203 ·Status: UNKNOWN
-
Dietary Supplementation on Tear Secretion and Inflammation in DES
NCT06738446 ·Status: COMPLETED ·Phase: NA
-
Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level
NCT05425914 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye
NCT03676335 ·Status: COMPLETED ·Phase: PHASE2
-
Three Dimension Tomography of Eye Structures by White Light Imaging Device
NCT02424266 ·Status: UNKNOWN
-
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503189 ·Status: COMPLETED ·Phase: PHASE3
-
The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome
NCT03666884 ·Status: COMPLETED ·Phase: PHASE4
-
Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
NCT06771427 ·Status: RECRUITING
-
The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression
NCT05713981 ·Status: COMPLETED ·Phase: NA
-
A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease
NCT00679718 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
NCT02121301 ·Status: COMPLETED ·Phase: PHASE2
-
Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome
NCT06475027 ·Status: NOT_YET_RECRUITING
-
The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease
NCT06824844 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
NCT05784519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2